Company STRATA Skin Sciences, Inc. Börse Stuttgart
Equities
E2O
US86272A3059
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.9 EUR | -9.38% | +778.79% | +494.26% |
05-15 | STRATA Skin Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-15 | Transcript : STRATA Skin Sciences, Inc., Q1 2024 Earnings Call, May 15, 2024 |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Dermatology Recurring Procedures
64.5
%
| 23 | 63.7 % | 22 | 64.5 % | -6.49% |
Dermatology Procedures Equipment
35.5
%
| 13 | 36.3 % | 12 | 35.5 % | -9.96% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
69.0
%
| 24 | 66.3 % | 23 | 69.0 % | -3.97% |
Other Foreign
12.8
%
| 4 | 10.3 % | 4 | 12.8 % | +14.79% |
China
10.0
%
| 5 | 13.1 % | 3 | 10.0 % | -29.70% |
South Korea
8.2
%
| 4 | 10.3 % | 3 | 8.2 % | -26.59% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dolev Rafaeli
CEO | Chief Executive Officer | 60 | 09/04/18 |
Director of Finance/CFO | 42 | 05/07/21 | |
Shmuel Gov
COO | Chief Operating Officer | - | 31/12/14 |
Amandeep Kaur
SAM | Sales & Marketing | - | 12-03 |
Brent Cowgill
SAM | Sales & Marketing | - | 01/08/21 |
John Bagdasarian
PRN | Corporate Officer/Principal | - | 13/03/22 |
Jay Sturm
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Uri Geiger
CHM | Chairman | 56 | 28/05/18 |
Dolev Rafaeli
CEO | Chief Executive Officer | 60 | 09/04/18 |
Director/Board Member | 60 | 28/05/18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,506,092 | 2,082,935 ( 59.41 %) | 0 | 59.41 % |
Company contact information
STRATA Skin Sciences, Inc.
5 Walnut Grove Drive Suite 140
19044, Horsham
+215 619 3200
http://www.strataskinsciences.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.59% | 207B | |
+3.92% | 181B | |
+30.07% | 155B | |
+32.42% | 112B | |
+1.98% | 64.42B | |
+19.65% | 54.38B | |
-1.86% | 47.43B | |
-9.53% | 37.17B | |
-1.28% | 34.81B |
- Stock Market
- Equities
- SSKN Stock
- E2O Stock
- Company STRATA Skin Sciences, Inc.